Eleonora Ciampi
Genoa, 16147, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Antitumor Activity of Liposomal Nanoparticles Co-Encapsulating Ceramides and Doxorubicin in In Vitro Nucleolin-Expressing Neuroblastoma Models.
Journal: Cells
Published: April 29, 2026
The gamma delta T/NK cell product GADEKILL as a novel immunotherapeutic tool for neuroblastoma patients: role of B7H6 and BTN2A1 in tumor cell killing.
Journal: Frontiers in immunology
Published: November 27, 2025
Olive Leaf Extract (OLE) Anti-Tumor Activities Against Hematologic Tumors: Potential Therapeutic Implications for Pediatric Patients with B-Acute Lymphoblastic Leukemia.
Journal: Nutrients
Published: November 13, 2025
Patient-derived neuroblastoma models are sensitive to nucleolin-recognizing liposomal drugs.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: September 14, 2025
The investigational anti-B7-H3 antibody-drug conjugate vobramitamab duocarmazine exerts anti-tumor activity in vitro and in vivo in pediatric sarcoma preclinical models.
Journal: Cell death & disease
Published: June 23, 2025
From the identification of actionable molecular targets to the generation of faithful neuroblastoma patient-derived preclinical models.
Journal: Journal of translational medicine
Published: October 25, 2023
Antitumor activity of the investigational B7-H3 antibody-drug conjugate, vobramitamab duocarmazine, in preclinical models of neuroblastoma.
Journal: Journal for immunotherapy of cancer
Published: August 27, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026